| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |